Integration of Oxygen Signaling at the Consensus HRE
Abstract
The hypoxia-inducible factor 1 (HIF-1) was initially identified as a transcription factor that regulated erythropoietin gene expression in response to a decrease in oxygen availability in kidney tissue. Subsequently, a family of oxygen-dependent protein hydroxylases was found to regulate the abundance and activity of three oxygen-sensitive HIFα subunits, which, as part of the HIF heterodimer, regulated the transcription of at least 70 different effector genes. In addition to responding to a decrease in tissue oxygenation, HIF is proactively induced, even under normoxic conditions, in response to stimuli that lead to cell growth, ultimately leading to higher oxygen consumption. The growing cell thus profits from an anticipatory increase in HIF-dependent target gene expression. Growth stimuli–activated signaling pathways that influence the abundance and activity of HIFs include pathways in which kinases are activated and pathways in which reactive oxygen species are liberated. These pathways signal to the HIF protein hydroxylases, as well as to HIF itself, by means of covalent or redox modifications and protein-protein interactions. The final point of integration of all of these pathways is the hypoxia-response element (HRE) of effector genes. Here, we provide comprehensive compilations of the known growth stimuli that promote increases in HIF abundance, of protein-protein interactions involving HIF, and of the known HIF effector genes. The consensus HRE derived from a comparison of the HREs of these HIF effectors will be useful for identification of novel HIF target genes, design of oxygen-regulated gene therapy, and prediction of effects of future drugs targeting the HIF system.
Abstract
Oxygen availability regulates many physiological and pathophysiological processes, including embryonic development, high-altitude adaptation, wound healing, and inflammation, as well as contributing to the pathophysiology of ischemic diseases and cancer. Central to our understanding of these processes is an elucidation of the molecular mechanisms by which cells react and adapt to insufficient oxygen supply (hypoxia). The last few years have brought a wealth of novel insights into these processes. Oxygen-sensing protein hydroxylases have been discovered that regulate the abundance and activity of three hypoxia-inducible transcription factors (HIFs) and thereby the activity of at least 70 effector genes involved in hypoxic adaptation. In addition to the increase in HIF abundance in response to a decrease in tissue oxygenation, it became evident that HIF abundance is also proactively increased, even under normoxic conditions, in response to stimuli that lead to cell growth and thus ultimately require higher oxygen consumption. The growing cell thus profits from an anticipatory increase in HIF-dependent target gene expression. Growth stimuli–activated signaling pathways that influence the abundance and activity of HIFs include pathways that involve the activation of kinases and liberation of reactive oxygen species. All of these pathways converge at the hypoxia-response elements (HREs) of effector genes, to which the HIFs bind, thereby enabling HIF-dependent induction of gene expression.
Get full access to this article
View all available purchase options and get full access to this article.
Already a Subscriber?Sign In
References
1.
G. L. Semenza, Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551–578 (1999).
2.
R. H. Wenger, Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16, 1151–1162 (2002).
3.
K. A. Seta, Z. Spicer, Y. Yuan, G. Lu, D. E. Millhorn, Responding to hypoxia: Lessons from a model cell line. Sci. STKE 2002, re11 (2002).
4.
C. J. Schofield, P. J. Ratcliffe, Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343–354 (2004).
5.
W. G. Kaelin, Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74, 115–128 (2005).
6.
P. Jaakkola, D. R. Mole, Y. M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, A. von Kriegsheim, H. F. Hebestreit, M. Mukherji, C. J. Schofield, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468–472 (2001).
7.
M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, W. G. Kaelin, Jr., HIFα targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292, 464–468 (2001).
8.
N. Masson, C. Willam, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20, 5197–5206 (2001).
9.
F. Yu, S. B. White, Q. Zhao, F. S. Lee, HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U.S.A. 98, 9630–9635 (2001).
10.
A. C. Epstein, J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O’Rourke, D. R. Mole, M. Mukherji, E. Metzen, M. I. Wilson, A. Dhanda, Y. M. Tian, N. Masson, D. L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P. H. Maxwell, C. W. Pugh, C. J. Schofield, P. J. Ratcliffe, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001).
11.
R. K. Bruick, S. L. McKnight, A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337–1340 (2001).
12.
F. Oehme, P. Ellinghaus, P. Kolkhof, T. J. Smith, S. Ramakrishnan, J. Hutter, M. Schramm, I. Flamme, Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343–349 (2002).
13.
P. H. Maxwell, M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, P. J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).
14.
U. R. Jewell, I. Kvietikova, A. Scheid, C. Bauer, R. H. Wenger, M. Gassmann, Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J. 15, 1312–1314 (2001).
15.
P. C. Mahon, K. Hirota, G. L. Semenza, FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675–2686 (2001).
16.
D. Lando, D. J. Peet, J. J. Gorman, D. A. Whelan, M. L. Whitelaw, R. K. Bruick, FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466–1471 (2002).
17.
H. J. Knowles, R. R. Raval, A. L. Harris, P. J. Ratcliffe, Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63, 1764–1768 (2003).
18.
F. Martin, T. Linden, D. M. Katschinski, F. Oehme, I. Flamme, C. K. Mukhopadhyay, K. Eckhardt, J. Tröger, S. Barth, G. Camenisch, R. H. Wenger, Copper-dependent activation of hypoxia-inducible factor (HIF)-1: Implications for ceruloplasmin regulation. Blood 105, 4613–4619 (2005).
19.
M. Hirsilä, P. Koivunen, L. Xu, T. Seeley, K. I. Kivirikko, J. Myllyharju, Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19, 1308–1310 (2005).
20.
D. Gerald, E. Berra, Y. M. Frapart, D. A. Chan, A. J. Giaccia, D. Mansuy, J. Pouysségur, M. Yaniv, F. Mechta-Grigoriou, JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118, 781–794 (2004).
21.
E. Metzen, J. Zhou, W. Jelkmann, J. Fandrey, B. Brüne, Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14, 3470–3481 (2003).
22.
C. L. Dalgard, H. Lu, A. Mohyeldin, A. Verma, Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem. J. 380, 419–424 (2004).
23.
M. A. Selak, S. M. Armour, E. D. MacKenzie, H. Boulahbel, D. G. Watson, K. D. Mansfield, Y. Pan, M. C. Simon, C. B. Thompson, E. Gottlieb, Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77–85 (2005).
24.
D. Dupuy, I. Aubert, V. G. Dupérat, J. Petit, L. Taine, M. Stef, B. Bloch, B. Arveiler, Mapping, characterization, and expression analysis of the SM-20 human homologue, c1orf12, and identification of a novel related gene, SCAND2. Genomics 69, 348–354 (2000).
25.
M. E. Lieb, K. Menzies, M. C. Moschella, R. Ni, M. B. Taubman, Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell Biol. 80, 421–426 (2002).
26.
R. S. Freeman, D. M. Hasbani, E. A. Lipscomb, J. A. Straub, L. Xie, SM-20, EGL-9, and the EGLN family of hypoxia-inducible factor prolyl hydroxylases. Mol. Cells 16, 1–12 (2003).
27.
C. Willam, L. G. Nicholls, P. J. Ratcliffe, C. W. Pugh, P. H. Maxwell, The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor α. Adv. Enzyme Regul. 44, 75–92 (2004).
28.
R. J. Appelhoff, Y. M. Tian, R. R. Raval, H. Turley, A. L. Harris, C. W. Pugh, P. J. Ratcliffe, J. M. Gleadle, Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458–38465 (2004).
29.
T. Hagen, C. T. Taylor, F. Lam, S. Moncada, Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1α. Science 302, 1975–1978 (2003).
30.
T. Hofer, I. Desbaillets, G. Höpfl, M. Gassmann, R. H. Wenger, Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1α activation cascade: Implications for HIF-1α gene therapy. FASEB J. 15, 2715–2717 (2001).
31.
E. Berra, E. Benizri, A. Ginouves, V. Volmat, D. Roux, J. Pouysségur, HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22, 4082–4090 (2003).
32.
L. del Peso, M. C. Castellanos, E. Temes, S. Martin-Puig, Y. Cuevas, G. Olmos, M. O. Landázuri, The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278, 48690–48695 (2003).
33.
G. D’Angelo, E. Duplan, N. Boyer, P. Vigne, C. Frelin, Hypoxia up-regulates prolyl hydroxylase activity: A feedback mechanism that limits HIF-1 responses during reoxygenation. J. Biol. Chem. 278, 38183–38187 (2003).
34.
C. L. Cioffi, X. Q. Liu, P. A. Kosinski, M. Garay, B. R. Bowen, Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem. Biophys. Res. Commun. 303, 947–953 (2003).
35.
O. Aprelikova, G. V. Chandramouli, M. Wood, J. R. Vasselli, J. Riss, J. K. Maranchie, W. M. Linehan, J. C. Barrett, Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J. Cell. Biochem. 92, 491–501 (2004).
36.
J. H. Marxsen, P. Stengel, K. Doege, P. Heikkinen, T. Jokilehto, T. Wagner, W. Jelkmann, P. Jaakkola, E. Metzen, Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases. Biochem. J. 381, 761–767 (2004).
37.
E. Metzen, D. P. Stiehl, K. Doege, J. H. Marxsen, T. Hellwig-Bürgel, W. Jelkmann, Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: Identification of a functional hypoxia-responsive element. Biochem. J. 387, 711–717 (2005).
38.
E. Laughner, P. Taghavi, K. Chiles, P. C. Mahon, G. L. Semenza, HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995–4004 (2001).
39.
R. Fukuda, K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, G. L. Semenza, Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205–38211 (2002).
40.
R. H. Wenger, Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203, 1253–1263 (2000).
41.
K. B. Sandau, H. G. Faus, B. Brune, Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Biochem. Biophys. Res. Commun. 278, 263–267 (2000).
42.
L. A. Palmer, B. Gaston, R. A. Johns, Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: Redox-dependent effect of nitrogen oxides. Mol. Pharmacol. 58, 1197–1203 (2000).
43.
K. B. Sandau, J. Fandrey, B. Brune, Accumulation of HIF-1α under the influence of nitric oxide. Blood 97, 1009–1015 (2001).
44.
H. Kimura, A. Weisz, Y. Kurashima, K. Hashimoto, T. Ogura, F. D’Acquisto, R. Addeo, M. Makuuchi, H. Esumi, Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189–197 (2000).
45.
Y. Liu, H. Christou, T. Morita, E. Laughner, G. L. Semenza, S. Kourembanas, Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J. Biol. Chem. 273, 15257–15262 (1998).
46.
K. Sogawa, K. Numayamatsuruta, M. Ema, M. Abe, H. Abe, Y. Fujiikuriyama, Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc. Natl. Acad. Sci. U.S.A. 95, 7368–7373 (1998).
47.
L. E. Huang, W. G. Willmore, J. Gu, M. A. Goldberg, H. F. Bunn, Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J. Biol. Chem. 274, 9038–9044 (1999).
48.
J. H. Yin, D. I. Yang, G. Ku, C. Y. Hsu, iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem. Biophys. Res. Commun. 279, 30–34 (2000).
49.
J. Genius, J. Fandrey, Nitric oxide affects the production of reactive oxygen species in hepatoma cells: Implications for the process of oxygen sensing. Free Rad. Biol. Med. 29, 515–521 (2000).
50.
K. Doege, S. Heine, I. Jensen, W. Jelkmann, E. Metzen, Inhibition of mitochondrial respiration elevates oxygen concentration, but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106, 2311–2317 (2005).
51.
B. M. Emerling, L. C. Platanias, E. Black, A. R. Nebreda, R. J. Davis, N. S. Chandel, Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol. Cell. Biol. 25, 4853–4862 (2005).
52.
B. L. Ebert, H. F. Bunn, Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell. Biol. 18, 4089–4096 (1998).
53.
J. D. Firth, B. L. Ebert, P. J. Ratcliffe, Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270, 21021–21027 (1995).
54.
A. Damert, E. Ikeda, W. Risau, Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J. 327, 419–423 (1997).
55.
K. Ameri, B. Burke, C. E. Lewis, A. L. Harris, Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: Role of HIF-1. Br. J. Cancer 87, 1173–1181 (2002).
56.
H. I. Swanson, DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chem. Biol. Interact. 141, 63–76 (2002).
57.
G. Camenisch, D. M. Stroka, M. Gassmann, R. H. Wenger, Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression. Eur. J. Physiol. 443, 240–249 (2001).
58.
R. R. Raval, K. W. Lau, M. G. Tran, H. M. Sowter, S. J. Mandriota, J. L. Li, C. W. Pugh, P. H. Maxwell, A. L. Harris, P. J. Ratcliffe, Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 25, 5675–5686 (2005).
59.
G. Elvert, A. Kappel, R. Heidenreich, U. Englmeier, S. Lanz, T. Acker, M. Rauter, K. Plate, M. Sieweke, G. Breier, I. Flamme, Cooperative interaction of hypoxia-inducible factor-2α (HIF-2α) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J. Biol. Chem. 278, 7520–7530 (2003).
60.
C. Warnecke, Z. Zaborowska, J. Kurreck, V. A. Erdmann, U. Frei, M. Wiesener, K. U. Eckardt, Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: Erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J. 18, 1462–1464 (2004).
61.
M. Scortegagna, K. Ding, Q. Zhang, Y. Oktay, M. J. Bennett, M. Bennett, J. M. Shelton, J. A. Richardson, O. Moe, J. A. Garcia, HIF-2α regulates murine hematopoietic development in an erythropoietin-dependent manner. Blood 105, 3133–3140 (2005).
62.
X. Xie, J. Lu, E. J. Kulbokas, T. R. Golub, V. Mootha, K. Lindblad-Toh, E. S. Lander, M. Kellis, Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434, 338–345 (2005).
63.
A. Zagórska, J. Dulak, HIF-1: The knowns and unknowns of hypoxia sensing. Acta Biochim. Pol. 51, 563–585 (2004).
64.
R. H. Wenger, I. Kvietikova, A. Rolfs, G. Camenisch, M. Gassmann, Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur. J. Biochem. 253, 771–777 (1998).
65.
J. Rössler, I. Stolze, S. Frede, P. Freitag, L. Schweigerer, W. Havers, J. Fandrey, Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site. J. Cell. Biochem. 93, 153–161 (2004).
66.
I. Kvietikova, R. H. Wenger, H. H. Marti, M. Gassmann, The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res. 23, 4542–4550 (1995).
67.
I. Kvietikova, R. H. Wenger, H. H. Marti, M. Gassmann, The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int. 51, 564–566 (1997).
68.
B. Hu, E. Wright, L. Campbell, K. L. Blanchard, In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer. Mol. Cell. Biol. 17, 851–856 (1997).
69.
K. A. Ziel, V. Grishko, C. C. Campbell, J. F. Breit, G. L. Wilson, M. N. Gillespie, Oxidants in signal transduction: Impact on DNA integrity and gene expression. FASEB J. 19, 387–394 (2005).
70.
H. Rodriguez, R. Drouin, G. P. Holmquist, S. A. Akman, A hot spot for hydrogen peroxide-induced damage in the human hypoxia-inducible factor 1 binding site of the PGK 1 gene. Arch. Biochem. Biophys. 338, 207–212 (1997).
71.
E. S. Henle, Z. Han, N. Tang, P. Rai, Y. Luo, S. Linn, Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J. Biol. Chem. 274, 962–971 (1999).
72.
J. M. Brown, W. R. Wilson, Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4, 437–447 (2004).
73.
B. Z. Olenyuk, G. J. Zhang, J. M. Klco, N. G. Nickols, W. G. Kaelin, Jr., P. B. Dervan, Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. U.S.A. 101, 16768–16773 (2004).
74.
N. Masson, R. J. Appelhoff, J. R. Tuckerman, Y. M. Tian, H. Demol, M. Puype, J. Vandekerckhove, P. J. Ratcliffe, C. W. Pugh, The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett. 570, 166–170 (2004).
75.
K. Nakayama, I. J. Frew, M. Hagensen, M. Skals, H. Habelhah, A. Bhoumik, T. Kadoya, H. Erdjument-Bromage, P. Tempst, P. B. Frappell, D. D. Bowtell, Z. Ronai, Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 117, 941–952 (2004).
76.
J. H. Baek, P. C. Mahon, J. Oh, B. Kelly, B. Krishnamachary, M. Pearson, D. A. Chan, A. J. Giaccia, G. L. Semenza, OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α. Mol. Cell 17, 503–512 (2005).
77.
D. Lando, D. J. Peet, D. A. Whelan, J. J. Gorman, M. L. Whitelaw, Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science 295, 858–861 (2002).
78.
K. S. Hewitson, L. A. McNeill, M. V. Riordan, Y. M. Tian, A. N. Bullock, R. W. Welford, J. M. Elkins, N. J. Oldham, S. Bhattacharya, J. M. Gleadle, P. J. Ratcliffe, C. W. Pugh, C. J. Schofield, Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351–26355 (2002).
79.
A. Ozer, L. C. Wu, R. K. Bruick, The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl. Acad. Sci. U.S.A. 102, 7481–7486 (2005).
80.
H. Qi, M. L. Gervais, W. Li, J. A. DeCaprio, J. R. G. Challis, M. Ohh, Molecular cloning and characterization of the von Hippel-Lindau-like protein. Mol. Cancer Res. 2, 43–52 (2004).
81.
Z. Li, D. Wang, E. M. Messing, G. Wu, VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α. EMBO Rep. 6, 373–378 (2005).
82.
J. W. Jeong, M. K. Bae, M. Y. Ahn, S. H. Kim, T. K. Sohn, M. H. Bae, M. A. Yoo, E. J. Song, K. J. Lee, K. W. Kim, Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111, 709–720 (2002).
83.
S. Cho, Y. J. Choi, J. M. Kim, S. T. Jeong, J. H. Kim, S. H. Kim, S. E. Ryu, Binding and regulation of HIF-1α by a subunit of the proteasome complex, PSMA7. FEBS Lett. 498, 62–66 (2001).
84.
K. Gradin, J. McGuire, R. H. Wenger, I. Kvietikova, M. L. Whitelaw, R. Toftgård, L. Tora, M. Gassmann, L. Poellinger, Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16, 5221–5231 (1996).
85.
D. M. Katschinski, L. Le, D. Heinrich, K. F. Wagner, T. Hofer, S. G. Schindler, R. H. Wenger, Heat induction of the unphosphorylated form of hypoxia-inducible factor-1α is dependent on heat shock protein-90 activity. J. Biol. Chem. 277, 9262–9267 (2002).
86.
D. M. Katschinski, L. Le, S. G. Schindler, T. Thomas, A. K. Voss, R. H. Wenger, Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1α stabilization. Cell. Physiol. Biochem. 14, 351–360 (2004).
87.
J. S. Isaacs, Y. J. Jung, E. G. Mimnaugh, A. Martinez, F. Cuttitta, L. M. Neckers, Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway. J. Biol. Chem. 277, 29936–29944 (2002).
88.
J. Zhou, T. Schmid, R. Frank, B. Brüne, PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1α from pVHL-independent degradation. J. Biol. Chem. 279, 13506–13513 (2004).
89.
W. G. An, M. Kanekal, M. C. Simon, E. Maltepe, M. V. Blagosklonny, L. M. Neckers, Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392, 405–408 (1998).
90.
R. Ravi, B. Mookerjee, Z. M. Bhujwalla, C. H. Sutter, D. Artemov, Q. Zeng, L. E. Dillehay, A. Madan, G. L. Semenza, A. Bedi, Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14, 34–44 (2000).
91.
D. Chen, M. Li, J. Luo, W. Gu, Direct interactions between HIF-1α and Mdm2 modulate p53 function. J. Biol. Chem. 278, 13595–13598 (2003).
92.
A. L. Nieminen, S. Qanungo, E. A. Schneider, B. H. Jiang, F. H. Agani, Mdm2 and HIF-1α interaction in tumor cells during hypoxia. J. Cell. Physiol. 204, 364–369 (2005).
93.
M. K. Bae, M. Y. Ahn, J. W. Jeong, M. H. Bae, Y. M. Lee, S. K. Bae, J. W. Park, K. R. Kim, K. W. Kim, Jab1 interacts directly with HIF-1α and regulates its stability. J. Biol. Chem. 277, 9–12 (2002).
94.
L. Bemis, D. A. Chan, C. V. Finkielstein, L. Qi, P. D. Sutphin, X. Chen, K. Stenmark, A. J. Giaccia, W. Zundel, Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5. Genes Dev. 18, 739–744 (2004).
95.
R. Shao, F. P. Zhang, F. Tian, P. Anders Friberg, X. Wang, H. Sjöland, H. Billig, Increase of SUMO-1 expression in response to hypoxia: Direct interaction with HIF-1α in adult mouse brain and heart in vivo. FEBS Lett. 569, 293–300 (2004).
96.
D. E. Richard, E. Berra, E. Gothie, D. Roux, J. Pouysségur, p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274, 32631–32637 (1999).
97.
E. Y. Chen, N. M. Mazure, J. A. Cooper, A. J. Giaccia, Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res. 61, 2429–2433 (2001).
98.
J. H. Um, C. D. Kang, J. H. Bae, G. G. Shin, W. Kim do, D. W. Kim, B. S. Chung, S. H. Kim, Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells. Exp. Mol. Med. 36, 233–242 (2004).
99.
D. Chilov, T. Hofer, C. Bauer, R. H. Wenger, M. Gassmann, Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J. 15, 2613–2622 (2001).
100.
J. Cho, D. Kim, S. Lee, Y. Lee, Cobalt chloride-induced estrogen receptor α down-regulation involves hypoxia-inducible factor-1α in MCF-7 human breast cancer cells. Mol. Endocrinol. 19, 1191–1199 (2005).
101.
G. L. Wang, B. H. Jiang, E. A. Rue, G. L. Semenza, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510–5514 (1995).
102.
B. H. Jiang, E. Rue, G. L. Wang, R. Roe, G. L. Semenza, Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771–17778 (1996).
103.
A. Chapman-Smith, J. K. Lutwyche, M. L. Whitelaw, Contribution of the Per/Arnt/Sim (PAS) domains to DNA binding by the basic helix-loop-helix PAS transcriptional regulators. J. Biol. Chem. 279, 5353–5362 (2004).
104.
Z. Arany, L. E. Huang, R. Eckner, S. Bhattacharya, C. Jiang, M. A. Goldberg, H. F. Bunn, D. M. Livingston, An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 93, 12969–12973 (1996).
105.
P. J. Kallio, K. Okamoto, S. O’Brien, P. Carrero, Y. Makino, H. Tanaka, L. Poellinger, Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J. 17, 6573–6586 (1998).
106.
M. Ema, K. Hirota, J. Mimura, H. Abe, J. Yodoi, K. Sogawa, L. Poellinger, Y. Fujii-Kuriyama, Molecular mechanisms of transcription activation by HLF and HIF1-α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905–1914 (1999).
107.
P. Carrero, K. Okamoto, P. Coumailleau, S. O’Brien, H. Tanaka, L. Poellinger, Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α. Mol. Cell. Biol. 20, 402–415 (2000).
108.
J. Gu, J. Milligan, L. E. Huang, Molecular mechanism of hypoxia-inducible factor 1α-p300 interaction. a leucine-rich interface regulated by a single cysteine. J. Biol. Chem. 276, 3550–3554 (2001).
109.
J. L. Ruas, L. Poellinger, T. Pereira, Role of CBP in regulating HIF-1-mediated activation of transcription. J. Cell Sci. 118, 301–311 (2005).
110.
H. Kato, S. Tamamizu-Kato, F. Shibasaki, Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity. J. Biol. Chem. 279, 41966–41974 (2004).
111.
D. Lando, I. Pongratz, L. Poellinger, M. L. Whitelaw, A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like factor. J. Biol. Chem. 275, 4618–4627 (2000).
112.
W. Zhang, T. Tsuchiya, Y. Yasukochi, Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. J. Hum. Genet. 44, 293–299 (1999).
113.
T. Tsuchiya, Y. Kominato, M. Ueda, Human hypoxic signal transduction through a signature motif in hepatocyte nuclear factor 4. J. Biochem. (Tokyo) 132, 37–44 (2002).
114.
T. Sánchez-Elsner, L. M. Botella, B. Velasco, A. Corbi, L. Attisano, C. Bernabeu, Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276, 38527–38535 (2001).
115.
T. Sánchez-Elsner, J. R. Ramírez, F. Rodriguez-Sanz, E. Varela, C. Bernabéu, L. M. Botella, A cross-talk between hypoxia and TGF-β orchestrates erythropoietin gene regulation through SP1 and Smads. J. Mol. Biol. 336, 9–24 (2004).
116.
M. J. Gray, J. Zhang, L. M. Ellis, G. L. Semenza, D. B. Evans, S. S. Watowich, G. E. Gallick, HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24, 3110–3120 (2005).
117.
Y. Jiang, Z. H. Xue, W. Z. Shen, K. M. Du, H. Yan, Y. Yu, Z. G. Peng, M. G. Song, J. H. Tong, Z. Chen, Y. Huang, M. Lubbert, G. Q. Chen, Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α. Leukemia 19, 1239–1247 (2005).
118.
M. Koshiji, Y. Kageyama, E. A. Pete, I. Horikawa, J. C. Barrett, L. E. Huang, HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23, 1949–1956 (2004).
119.
K. Fatyol, A. A. Szalay, The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1α (HIF-1α) and inhibits HIF-1-mediated transcription. J. Biol. Chem. 276, 28421–28429 (2001).
120.
Y. G. Yoo, S. Cho, S. Park, M. O. Lee, The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1α. FEBS Lett. 577, 121–126 (2004).
121.
F. Wang, R. Zhang, T. V. Beischlag, C. Muchardt, M. Yaniv, O. Hankinson, Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J. Biol. Chem. 279, 46733–46741 (2004).
122.
T. V. Beischlag, R. T. Taylor, D. W. Rose, D. Yoon, Y. Chen, W. H. Lee, M. G. Rosenfeld, O. Hankinson, Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia. J. Biol. Chem. 279, 54620–54628 (2004).
123.
A. Budde, N. Schneiderhan-Marra, G. Petersen, B. Brüne, Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1). Oncogene 24, 1802–1808 (2005).
124.
C. P. Bracken, M. L. Whitelaw, D. J. Peet, Activity of hypoxia-inducible factor 2α is regulated by association with the NF-κB essential modulator. J. Biol. Chem. 280, 14240–14251 (2005).
125.
E. Zelzer, Y. Levy, C. Kahana, B. Z. Shilo, M. Rubinstein, B. Cohen, Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17, 5085–5094 (1998).
126.
D. Feldser, F. Agani, N. V. Iyer, B. Pak, G. Ferreira, G. L. Semenza, Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res. 59, 3915–3918 (1999).
127.
B. H. Jiang, G. Jiang, J. Z. Zheng, Z. Lu, T. Hunter, P. K. Vogt, Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363–369 (2001).
128.
D. P. Stiehl, W. Jelkmann, R. H. Wenger, T. Hellwig-Bürgel, Normoxic induction of the hypoxia-inducible factor-1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512, 157–162 (2002).
129.
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G. L. Semenza, E. Van Obberghen, Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277, 27975–27981 (2002).
130.
D. E. Richard, E. Berra, J. Pouysségur, Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J. Biol. Chem. 275, 26765–26771 (2000).
131.
Y. H. Shi, Y. X. Wang, L. Bingle, L. H. Gong, W. J. Heng, Y. Li, W. G. Fang, In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: Involvement of PI-3K/Akt and MEK1/ERK pathways. J. Pathol. 205, 530–536 (2005).
132.
H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M. M. Georgescu, J. W. Simons, G. L. Semenza, Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541–1545 (2000).
133.
L. Tacchini, P. Dansi, E. Matteucci, M. A. Desiderio, Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22, 1363–1371 (2001).
134.
S. C. Shih, K. P. Claffey, Role of AP-1 and HIF-1 transcription factors in TGF-β activation of VEGF expression. Growth Factors 19, 19–34 (2001).
135.
T. Hellwig-Bürgel, K. Rutkowski, E. Metzen, J. Fandrey, W. Jelkmann, Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561–1567 (1999).
136.
R. D. Thornton, P. Lane, R. C. Borghaei, E. A. Pease, J. Caro, E. Mochan, Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350, 307–312 (2000).
137.
J. J. Haddad, S. C. Land, A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett. 505, 269–274 (2001).
138.
E. L. Pagé, G. A. Robitaille, J. Pouysségur, D. E. Richard, Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J. Biol. Chem. 277, 48403–48409 (2002).
139.
F. Spinella, L. Rosanò, V. Di Castro, P. G. Natali, A. Bagnato, Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1α in ovarian carcinoma cells. J. Biol. Chem. 277, 27850–27855 (2002).
140.
A. Görlach, I. Diebold, V. B. Schini-Kerth, U. Berchner-Pfannschmidt, U. Roth, R. P. Brandes, T. Kietzmann, R. Busse, Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells. Role of the p22phox-containing NADPH oxidase. Circ. Res. 89, 47–54 (2001).
141.
Y. G. Yoo, M. G. Yeo, D. K. Kim, H. Park, M. O. Lee, Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1α. J. Biol. Chem. 279, 53365–53373 (2004).
142.
H. Nakamura, Y. Makino, K. Okamoto, L. Poellinger, K. Ohnuma, C. Morimoto, H. Tanaka, TCR engagement increases hypoxia-inducible factor-1α protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol. 174, 7592–7599 (2005).
143.
N. J. Mabjeesh, M. T. Willard, C. E. Frederickson, H. Zhong, J. W. Simons, Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells. Clin. Cancer Res. 9, 2416–2425 (2003).
144.
Y. Ma, P. Freitag, J. Zhou, B. Brüne, S. Frede, J. Fandrey, Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia-inducible factor-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R600–R607 (2004).
145.
K. Hirota, R. Fukuda, S. Takabuchi, S. Kizaka-Kondoh, T. Adachi, K. Fukuda, G. L. Semenza, Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling. J. Biol. Chem. 279, 41521–41528 (2004).
146.
Y. Kakinuma, M. Ando, M. Kuwabara, R. G. Katare, K. Okudela, M. Kobayashi, T. Sato, Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1α. FEBS Lett. 579, 2111–2118 (2005).
147.
H. Alam, E. T. Maizels, Y. Park, S. Ghaey, Z. J. Feiger, N. S. Chandel, M. Hunzicker-Dunn, Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J. Biol. Chem. 279, 19431–19440 (2004).
148.
K. B. Sandau, H. G. Faus, B. Brüne, Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Biochem. Biophys. Res. Commun. 278, 263–267 (2000).
149.
C. C. Blouin, E. L. Page, G. M. Soucy, D. E. Richard, Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1α. Blood 103, 1124–1130 (2004).
150.
N. Wakisaka, S. Kondo, T. Yoshizaki, S. Murono, M. Furukawa, J. S. Pagano, Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1α. Mol. Cell. Biol. 24, 5223–5234 (2004).
151.
Y. G. Yoo, S. H. Oh, E. S. Park, H. Cho, N. Lee, H. Park, D. K. Kim, D. Y. Yu, J. K. Seong, M. O. Lee, Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1α through activation of mitogen-activated protein kinase pathway. J. Biol. Chem. 278, 39076–39084 (2003).
152.
A. Sodhi, S. Montaner, V. Patel, M. Zohar, C. Bais, E. A. Mesri, J. S. Gutkind, The Kaposi’s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res. 60, 4873–4880 (2000).
153.
H. Chang, K. G. Shyu, B. W. Wang, P. Kuan, Regulation of hypoxia-inducible factor-1α by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin. Sci. (Lond.) 105, 447–456 (2003).
154.
G. L. Wang, G. L. Semenza, Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood 82, 3610–3615 (1993).
155.
K. Salnikow, W. Su, M. V. Blagosklonny, M. Costa, Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60, 3375–3378 (2000).
156.
K. Salnikow, S. P. Donald, R. K. Bruick, A. Zhitkovich, J. M. Phang, K. S. Kasprzak, Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279, 40337–40344 (2004).
157.
D. Mottet, G. Michel, P. Renard, N. Ninane, M. Raes, C. Michiels, Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol. 194, 30–44 (2003).
158.
Y. S. Chun, E. Choi, G. T. Kim, M. J. Lee, M. J. Lee, S. E. Lee, M. S. Kim, J. W. Park, Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1α, but inhibits the nuclear translocation of HIF-1β, causing HIF-1 inactivation. Biochem. Biophys. Res. Commun. 268, 652–656 (2000).
159.
M. C. Duyndam, T. M. Hulscher, D. Fontijn, H. M. Pinedo, E. Boven, Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1α protein by the oxidative stressor arsenite. J. Biol. Chem. 276, 48066–48076 (2001).
160.
N. Gao, M. Ding, J. Z. Zheng, Z. Zhang, S. S. Leonard, K. J. Liu, X. Shi, B. H. Jiang, Vanadate-induced expression of hypoxia-inducible factor 1 α and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277, 31963–31971 (2002).
161.
N. Gao, B. H. Jiang, S. S. Leonard, L. Corum, Z. Zhang, J. R. Roberts, J. Antonini, J. Z. Zheng, D. C. Flynn, V. Castranova, X. Shi, p38 Signaling-mediated hypoxia-inducible factor 1α and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 277, 45041–45048 (2002).
162.
K. Mekhail, L. Gunaratnam, M. E. Bonicalzi, S. Lee, HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 6, 642–647 (2004).
163.
G. L. Wang, G. L. Semenza, Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268, 21513–21518 (1993).
164.
J. D. Firth, B. L. Ebert, C. W. Pugh, P. J. Ratcliffe, Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. U.S.A. 91, 6496–6500 (1994).
165.
G. L. Semenza, P. H. Roth, H. M. Fang, G. L. Wang, Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757–23763 (1994).
166.
T. A. Gorr, J. D. Cahn, H. Yamagata, H. F. Bunn, Hypoxia-induced synthesis of hemoglobin in the crustacean Daphnia magna is hypoxia-inducible factor-dependent. J. Biol. Chem. 279, 36038–36047 (2004).
167.
Y. L. Liu, S. O. Ang, D. A. Weigent, J. T. Prchal, J. R. Bloomer, Regulation of ferrochelatase gene expression by hypoxia. Life Sci. 75, 2035–2043 (2004).
168.
P. Krishnamurthy, D. D. Ross, T. Nakanishi, K. Bailey-Dell, S. Zhou, K. E. Mercer, B. Sarkadi, B. P. Sorrentino, J. D. Schuetz, The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218–24225 (2004).
169.
A. Rolfs, I. Kvietikova, M. Gassmann, R. H. Wenger, Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272, 20055–20062 (1997).
170.
L. Tacchini, L. Bianchi, A. Bernelli-Zazzera, G. Cairo, Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274, 24142–24146 (1999).
171.
C. N. Lok, P. Ponka, Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274, 24147–24152 (1999).
172.
C. K. Mukhopadhyay, B. Mazumder, P. L. Fox, Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275, 21048–21054 (2000).
173.
Y. Liu, S. R. Cox, T. Morita, S. Kourembanas, Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77, 638–643 (1995).
174.
J. A. Forsythe, B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, G. L. Semenza, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604–4613 (1996).
175.
A. P. Levy, N. S. Levy, S. Wegner, M. A. Goldberg, Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333–13340 (1995).
176.
H. P. Gerber, F. Condorelli, J. Park, N. Ferrara, Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659–23667 (1997).
177.
G. Ambrosini, A. K. Nath, M. R. Sierra-Honigmann, J. Flores-Riveros, Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J. Biol. Chem. 277, 34601–34609 (2002).
178.
A. Grosfeld, J. André, S. Hauguel-de Mouzon, E. Berra, J. Pouysségur, M. Guerre-Millo, Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J. Biol. Chem. 277, 42953–42957 (2002).
179.
G. Melillo, T. Musso, A. Sica, L. S. Taylor, G. W. Cox, L. Varesio, A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683–1693 (1995).
180.
L. A. Palmer, G. L. Semenza, M. H. Stoler, R. A. Johns, Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol. 274, L212–L219 (1998).
181.
F. Coulet, S. Nadaud, M. Agrapart, F. Soubrier, Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J. Biol. Chem. 278, 46230–46240 (2003).
182.
P. J. Lee, B. H. Jiang, B. Y. Chin, N. V. Iyer, J. Alam, G. L. Semenza, A. M. Choi, Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375–5381 (1997).
183.
J. Hu, D. J. Discher, N. H. Bishopric, K. A. Webster, Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245, 894–899 (1998).
184.
A. D. Eckhart, N. Yang, X. Xin, J. E. Faber, Characterization of the α1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 94, 9487–9492 (1997).
185.
S. V. Nguyen, W. C. Claycomb, Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem. Biophys. Res. Commun. 265, 382–386 (1999).
186.
S. Cormier-Regard, S. V. Nguyen, W. C. Claycomb, Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273, 17787–17792 (1998).
187.
T. Kietzmann, U. Roth, K. Jungermann, Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94, 4177–4185 (1999).
188.
T. Fink, A. Kazlauskas, L. Poellinger, P. Ebbesen, V. Zachar, Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99, 2077–2083 (2002).
189.
Y. S. Chun, J. Y. Hyun, Y. G. Kwak, I. S. Kim, C. H. Kim, E. Choi, M. S. Kim, J. W. Park, Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem. J. 370, 149–157 (2003).
190.
G. L. Semenza, B. H. Jiang, S. W. Leung, R. Passantino, J. P. Concordet, P. Maire, A. Giallongo, Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271, 32529–32537 (1996).
191.
K. K. Graven, Q. Yu, D. Pan, J. S. Roncarati, H. W. Farber, Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim. Biophys. Acta 1447, 208–218 (1999).
192.
S. Lu, X. Gu, S. Hoestje, D. E. Epner, Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim. Biophys. Acta 1574, 152–156 (2002).
193.
S. T. Okino, C. H. Chichester, J. P. Whitlock Jr., Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter. J. Biol. Chem. 273, 23837–23843 (1998).
194.
U. Roth, K. Curth, T. G. Unterman, T. Kietzmann, The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 279, 2623–2631 (2004).
195.
M. Obach, A. Navarro-Sabaté, J. Caro, X. Kong, J. Duran, M. Gómez, J. C. Perales, F. Ventura, J. L. Rosa, R. Bartrons, 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J. Biol. Chem. 279, 53562–53570 (2004).
196.
M. Fukasawa, T. Tsuchiya, E. Takayama, N. Shinomiya, K. Uyeda, R. Sakakibara, S. Seki, Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J. Biochem. (Tokyo) 136, 273–277 (2004).
197.
O. Minchenko, I. Opentanova, D. Minchenko, T. Ogura, H. Esumi, Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1α activation. FEBS Lett. 576, 14–20 (2004).
198.
J. H. Choi, M. J. Park, K. W. Kim, Y. H. Choi, S. H. Park, W. G. An, U. S. Yang, J. Cheong, Molecular mechanism of hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation. FEBS Lett. 579, 2795–2801 (2005).
199.
B. L. Ebert, J. D. Firth, P. J. Ratcliffe, Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270, 29083–29089 (1995).
200.
K. Grabmaier, A. d. W. MC, G. W. Verhaegh, J. A. Schalken, E. Oosterwijk, Strict regulation of CAIX(G250/MN) by HIF-1α in clear cell renal cell carcinoma. Oncogene 23, 5624–5631 (2004).
201.
C. Bierl, B. Voetsch, R. C. Jin, D. E. Handy, J. Loscalzo, Determinants of human plasma glutathione peroxidase (GPx-3) expression. J. Biol. Chem. 279, 26839–26845 (2004).
202.
V. Mastyugin, A. Mezentsev, W. X. Zhang, S. Ashkar, M. W. Dunn, M. Laniado-Schwartzman, Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia. J. Cell. Biochem. 91, 1218–1238 (2004).
203.
C. Fradette, P. du Souich, Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia. Br. J. Pharmacol. 140, 1146–1154 (2003).
204.
M. Liu, N. J. Alkayed, Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1α-linked induction of P450 2C11 epoxygenase in astrocytes. J. Cereb. Blood Flow Metab. 25, 939–948 (2005).
205.
K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C. Montalto, S. P. Colgan, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387–3394 (2002).
206.
S. I. Tazuke, N. M. Mazure, J. Sugawara, G. Carland, G. H. Faessen, L. F. Suen, J. C. Irwin, D. R. Powell, A. J. Giaccia, L. C. Giudice, Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl. Acad. Sci. U.S.A. 95, 10188–10193 (1998).
207.
L. Schäffer, A. Scheid, P. Spielmann, C. Breymann, R. Zimmermann, M. Meuli, M. Gassmann, H. H. Marti, R. H. Wenger, Oxygen-regulated expression of TGF-β3, a growth factor involved in trophoblast differentiation. Placenta 24, 941–950 (2003).
208.
H. Nishi, T. Nakada, M. Hokamura, Y. Osakabe, O. Itokazu, L. E. Huang, K. Isaka, Hypoxia-inducible factor-1 transactivates transforming growth factor-β3 in trophoblast. Endocrinology 145, 4113–4118 (2004).
209.
T. Sánchez-Elsner, L. M. Botella, B. Velasco, C. Langa, C. Bernabéu, Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J. Biol. Chem. 277, 43799–43808 (2002).
210.
D. F. Higgins, M. P. Biju, Y. Akai, A. Wutz, R. S. Johnson, V. H. Haase, Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol. Renal Physiol. 287, F1223–F1232 (2004).
211.
G. T. Furuta, J. R. Turner, C. T. Taylor, R. M. Hershberg, K. Comerford, S. Narravula, D. K. Podolsky, S. P. Colgan, Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027–1034 (2001).
212.
K. Synnestvedt, G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, S. P. Colgan, Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993–1002 (2002).
213.
N. Miki, M. Ikuta, T. Matsui, Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor α4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J. Biol. Chem. 279, 15025–15031 (2004).
214.
T. Shoshani, A. Faerman, I. Mett, E. Zelin, T. Tenne, S. Gorodin, Y. Moshel, S. Elbaz, A. Budanov, A. Chajut, H. Kalinski, I. Kamer, A. Rozen, O. Mor, E. Keshet, D. Leshkowitz, P. Einat, R. Skaliter, E. Feinstein, Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol. Cell. Biol. 22, 2283–2293 (2002).
215.
D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan, O. M. Tepper, N. Bastidas, M. E. Kleinman, J. M. Capla, R. D. Galiano, J. P. Levine, G. C. Gurtner, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858–864 (2004).
216.
P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E. J. Oakeley, W. Krek, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425, 307–311 (2003).
217.
J. W. Choi, S. C. Park, G. H. Kang, J. O. Liu, H. D. Youn, Nur77 activated by hypoxia-inducible factor-1α overproduces proopiomelanocortin in von Hippel-Lindau-mutated renal cell carcinoma. Cancer Res. 64, 35–39 (2004).
218.
S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano, P. M. Comoglio, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347–361 (2003).
219.
K. D. Wagner, N. Wagner, S. Wellmann, G. Schley, A. Bondke, H. Theres, H. Scholz, Oxygen-regulated expression of the Wilms’ tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J. 17, 1364–1366 (2003).
220.
H. Nishi, T. Nakada, S. Kyo, M. Inoue, J. W. Shay, K. Isaka, Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol. Cell. Biol. 24, 6076–6083 (2004).
221.
N. Yatabe, S. Kyo, Y. Maida, H. Nishi, M. Nakamura, T. Kanaya, M. Tanaka, K. Isaka, S. Ogawa, M. Inoue, HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene 23, 3708–3715 (2004).
222.
R. K. Bruick, Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. U.S.A. 97, 9082–9087 (2000).
223.
S. Kothari, J. Cizeau, E. McMillan-Ward, S. J. Israels, M. Bailes, K. Ens, L. A. Kirshenbaum, S. B. Gibson, BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 22, 4734–4744 (2003).
224.
J. Y. Kim, H. J. Ahn, J. H. Ryu, K. Suk, J. H. Park, BH3-only protein Noxa Is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1α. J. Exp. Med. 199, 113–124 (2004).
225.
G. Zhou, T. Golden, I. V. Aragon, R. E. Honkanen, Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade. J. Biol. Chem. 279, 46595–46605 (2004).
226.
J. P. Piret, E. Minet, J. P. Cosse, N. Ninane, C. Debacq, M. Raes, C. Michiels, Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J. Biol. Chem. 280, 9336–9344 (2005).
227.
J. Li, X. Zhang, D. P. Sejas, G. C. Bagby, Q. Pang, Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem. 279, 41275–41279 (2004).
228.
S. Bhattacharya, C. L. Michels, M. K. Leung, Z. P. Arany, A. L. Kung, D. M. Livingston, Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64–75 (1999).
229.
T. Löfstedt, A. Jögi, M. Sigvardsson, K. Gradin, L. Poellinger, S. Pahlman, H. Axelson, Induction of ID2 expression by hypoxia-inducible factor-1: A role in dedifferentiation of hypoxic neuroblastoma cells. J. Biol. Chem. 279, 39223–39231 (2004).
230.
M. Oikawa, M. Abe, H. Kurosawa, W. Hida, K. Shirato, Y. Sato, Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem. Biophys. Res. Commun. 289, 39–43 (2001).
231.
K. Miyazaki, T. Kawamoto, K. Tanimoto, M. Nishiyama, H. Honda, Y. Kato, Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J. Biol. Chem. 277, 47014–47021 (2002).
232.
S. D. Estes, D. L. Stoler, G. R. Anderson, Anoxic induction of a sarcoma virus-related VL30 retrotransposon is mediated by a cis-acting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor. J. Virol. 69, 6335–6341 (1995).
233.
M. Haque, D. A. Davis, V. Wang, I. Widmer, R. Yarchoan, Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: Relevance to lytic induction by hypoxia. J. Virol. 77, 6761–6768 (2003).
234.
S. Pillet, N. Le Guyader, T. Hofer, F. NguyenKhac, M. Koken, J. T. Aubin, S. Fichelson, M. Gassmann, F. Morinet, Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 327, 1–7 (2004).
235.
T. Kong, H. K. Eltzschig, J. Karhausen, S. P. Colgan, C. S. Shelley, Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of β2 integrin gene expression. Proc. Natl. Acad. Sci. U.S.A. 101, 10440–10445 (2004).
236.
S. Paris, H. Denis, E. Delaive, M. Dieu, V. Dumont, N. Ninane, M. Raes, C. Michiels, Up-regulation of 94-kDa glucose-regulated protein by hypoxia-inducible factor-1 in human endothelial cells in response to hypoxia. FEBS Lett. 579, 105–114 (2005).
237.
S. McMahon, F. Grondin, P. P. McDonald, D. E. Richard, C. M. Dubois, Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: Impact on the bioactivation of proproteins. J. Biol. Chem. 280, 6561–6569 (2005).
238.
B. L. Petrella, J. Lohi, C. E. Brinckerhoff, Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma. Oncogene 24, 1043–1052 (2005).
239.
Y. Takahashi, S. Takahashi, Y. Shiga, T. Yoshimi, T. Miura, Hypoxic induction of prolyl 4-hydroxylase α (I) in cultured cells. J. Biol. Chem. 275, 14139–14146 (2000).
240.
N. Pescador, Y. Cuevas, S. Naranjo, M. Alcaide, D. Villar, M. O. Landazuri, L. Del Peso, Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390, 189–197 (2005).
241.
We thank B. Egli for secretarial assistance. Supported by grants from the Swiss National Science Foundation (3100A0-104219) and the 6th Framework Programme of the European Union (EUROXY LSHC-CT-2003-502932/Swiss State Secretariat for Education and Research SER No. 03.0647-2).
Information & Authors
Information
Published In
Science's STKE
Volume 2005 | Issue 306
October 2005
October 2005
Copyright
American Association for the Advancement of Science.
Authors
Metrics & Citations
Metrics
Article Usage
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Hypoxia and hypoxia‐inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula, The Journal of Physiology, 599, 8, (2299-2321), (2021).https://doi.org/10.1113/JP281218
- Interfering with Tumor Hypoxia for Radiotherapy Optimization, Journal of Experimental & Clinical Cancer Research, 40, 1, (2021).https://doi.org/10.1186/s13046-021-02000-x
- HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes, Proceedings of the National Academy of Sciences, 118, 26, (e2106017118), (2021).https://doi.org/10.1073/pnas.2106017118
- Population Genomics of High-Altitude Adaptation, Evolution of the Human Genome II, (67-100), (2021).https://doi.org/10.1007/978-4-431-56904-6_3
- Effects of warming rates on physiological and molecular components of response to CTMax heat stress in the Antarctic fish Harpagifer antarcticus, Journal of Thermal Biology, 99, (103021), (2021).https://doi.org/10.1016/j.jtherbio.2021.103021
- Differential expression and hypoxia‐mediated regulation of the N‐myc downstream regulated gene family, The FASEB Journal, 35, 11, (2021).https://doi.org/10.1096/fj.202100443R
- Lysine demethylase KDM6B regulates HIF-1α-mediated systemic and cellular responses to intermittent hypoxia, Physiological Genomics, 53, 9, (385-394), (2021).https://doi.org/10.1152/physiolgenomics.00045.2021
- Chronic fatigue syndrome and epigenetics: The case for hyperbaric oxygen therapy in biomarker identification, Journal of Pulmonology and Respiratory Research, 5, 1, (027-030), (2021).https://doi.org/10.29328/journal.jprr.1001020
- Drug-induced regeneration in adult mice, Science Translational Medicine, 7, 290, (290ra92-290ra92), (2021)./doi/10.1126/scitranslmed.3010228
- Science Signaling Podcast: 13 January 2009, Science Signaling, 2, 53, (pc1-pc1), (2021)./doi/10.1126/scisignal.253pc1
- See more
Loading...
View Options
Get Access
Log in to view the full text
AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.
- Become a AAAS Member
- Activate your AAAS ID
- Purchase Access to Other Journals in the Science Family
- Account Help
Log in via OpenAthens.
Log in via Shibboleth.
More options
Purchase digital access to this article
Download and print this article for your personal scholarly, research, and educational use.
View options
PDF format
Download this article as a PDF file
Download PDF